Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$60.0 - $68.46 $528,420 - $602,927
-8,807 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$56.65 - $64.55 $498,916 - $568,491
8,807 New
8,807 $502,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Aqr Arbitrage LLC Portfolio

Follow Aqr Arbitrage LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Arbitrage LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Arbitrage LLC with notifications on news.